TV4 morning show: Report: New Drugs Are Not Reaching All Breast Cancer Patients
Advances in breast cancer research are providing entirely new opportunities to diagnose and treat the most common cancer among women. Today, the Breast Cancer Association is releasing a report on access to the advanced diagnostic methods needed to determine whether a patient will benefit from specific medications, known as precision diagnostics. Susanne Dieroff Hay, Chair of the Breast Cancer Association, and Johan Hartman, tumor pathologist at Karolinska University Hospital, share their insights.
Unilabs Sverige and St. Göran’s Hospital are soon adopting Stratipath Breast for breast cancer risk profiling.
Johan Hartman is a guest at the Johnson & Johnson podcast “Vi forskar för livet” (“Research for Life”). The episode, titled “Precision Medicine is the Future of Healthcare – But Do We Have the Skills Needed?”